Why Strategic Education (STRA) shares are plunging today

Strategic Education (STRA) shares fell 17.1% after reporting a Q3 loss due to a $134.1M impairment charge related to Torrens University. Revenue increased slightly, but adjusted earnings of $1.72 missed estimates. The company maintained its dividend. STRA is down 20.3% YTD and 29.6% below its 52-week high.

Original reporting
Published Nov 5, 2026, 5:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 6:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Strategic Education (STRA) shares are plunging today — source image
Decision brief

The 30-second read

$STRABearishHigh
01

Why it matters

The earnings miss and impairment caused a 17.1% intraday decline, highlighting immediate downside risk.

02

Market read

The surprise earnings miss and sizable impairment are likely to keep STRA under pressure in the short term.

03

What to watch

Revenue was slightly higher YoY and operating profit remained steady, indicating underlying resilience.

Relevance 8/10Novelty 8/10Timing: afternoon session today

Background

Strategic Education reported Q3 results with an impairment charge tied to Torrens University and a slight revenue increase.

Company-level read

Ticker impact

$STRABearishHigh confidence
Context

Q3 2026 earnings miss with a $134.1M impairment charge caused a 17.1% share drop.

Expected impact

likely further pressure as investors price in lower outlook and the non‑cash charge.

Evidence & confidence

The impairment is material and the stock already fell 17% on the news; no mitigating catalyst was mentioned.

Market effects

Higher‑education sector may see heightened scrutiny on international‑student exposure.

U.S. education stocks could face short‑term volatility.

Limited to U.S. listed education companies.

Counterpoint

The impairment is non‑cash; the core business remains stable, offering a potential buying opportunity at a discount.

Key entities

  • Strategic Education

    U.S. higher‑education provider listed on NASDAQ.

Related articles

$STRAMed

Strategic Education Inc (STRA) (Q3 2026) Earnings Call Highlights: Healthcare and ETS

Strategic Education Inc (STRA) reported Q3 2026 results with Education Technology Services revenue up 12% to $43M and U.S. Healthcare enrollment growing 9%. However, Australia segment revenue declined 7% due to international student restrictions, and consolidated revenue was flat at $320M. The company expects 2027 revenue to be flat and sees margin pressure in ETS and U.S. Higher Education.

$STRAMed

Strategic Education Earnings Call Signals Recovery Amid Pressure

Strategic Education (STRA) reported mixed Q3 results, with EPS up 4% to $1.69 and free cash flow up 8% to $137M. Revenue was flat at $320M, and operating income declined 2%. Growth areas included Education Technology Services and healthcare enrollment, while Australian international restrictions and a $134M impairment weighed on results. Management expects flat 2027 revenue and plans increased investments in healthcare and education technology.

$STRAMed

What Strategic Education (STRA) Said on Its Q3 Earnings Call

Strategic Education (STRA) reported a 1% decline in U.S. Higher Education enrollment, driven by international student visa issues. Domestic enrollment grew 9%, and the company plans campus expansions. Technology and Healthcare segments drove revenue growth, with Education Technology Services up 12% and Healthcare enrollment up 9%. STRA repurchased 347,000 shares and has $139M in cash.

$STRAMed

Strategic Education (STRA) Q3 2026 Earnings Call Transcript

Strategic Education (STRA) reported Q3 2026 results. Free cash flow rose 8% to $137M. Education Technology Services revenue grew 12% to $43M, with operating margin expanding 80 bps. Sophia Learning subscribers increased 22%, and revenue grew 20%. U.S. Higher Education enrollment fell 1% to 84,700, but healthcare enrollment grew 9%. Australia saw a 9% enrollment decline due to government restrictions, leading to a $134M impairment.

$STRAMed

Strategic Education Reports Q3 2026 Results, $1.69 Adjusted EPS

Strategic Education reported Q3 2026 revenue of $325.1M, up 1.6% YoY, and adjusted EPS of $1.69. A $134.1M impairment charge led to an operating loss of $87.6M. Enrollment declined in U.S. Higher Education and Australia/New Zealand, while Sophia Learning and Education Technology Services grew. The company declared a $0.60 quarterly dividend.